Global Sepsis Diagnostics Testing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04255805

Publication Date:

April 24, 2025

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Sepsis Diagnostics Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淪epsis Diagnostics Testing Industry Forecast鈥� looks at past sales and reviews total world Sepsis Diagnostics Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Sepsis Diagnostics Testing sales for 2025 through 2031. With Sepsis Diagnostics Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sepsis Diagnostics Testing industry.
This Insight Report provides a comprehensive analysis of the global Sepsis Diagnostics Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sepsis Diagnostics Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Sepsis Diagnostics Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sepsis Diagnostics Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sepsis Diagnostics Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Sepsis Diagnostics Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Point-of-Care Testing
Laboratory Testing
Segmentation by Application:
General Hospitals
Specialty Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Axis Shield
Becton Dickinson
产颈辞惭茅谤颈别耻虫
Bruker
Cytosorbents
Danaher
Immunexpress
Luminex
Mitsubishi Chemical
Response Biomedical
Roche
T2 Biosystems
Thermo Fisher Scientific

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sepsis Diagnostics Testing Market Size (2020-2031)
2.1.2 Sepsis Diagnostics Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Sepsis Diagnostics Testing by Country/Region (2020, 2024 & 2031)
2.2 Sepsis Diagnostics Testing Segment by Type
2.2.1 Point-of-Care Testing
2.2.2 Laboratory Testing
2.3 Sepsis Diagnostics Testing Market Size by Type
2.3.1 Sepsis Diagnostics Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Sepsis Diagnostics Testing Market Size Market Share by Type (2020-2025)
2.4 Sepsis Diagnostics Testing Segment by Application
2.4.1 General Hospitals
2.4.2 Specialty Clinics
2.5 Sepsis Diagnostics Testing Market Size by Application
2.5.1 Sepsis Diagnostics Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Sepsis Diagnostics Testing Market Size Market Share by Application (2020-2025)
3 Sepsis Diagnostics Testing Market Size by Player
3.1 Sepsis Diagnostics Testing Market Size Market Share by Player
3.1.1 Global Sepsis Diagnostics Testing Revenue by Player (2020-2025)
3.1.2 Global Sepsis Diagnostics Testing Revenue Market Share by Player (2020-2025)
3.2 Global Sepsis Diagnostics Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Sepsis Diagnostics Testing by Region
4.1 Sepsis Diagnostics Testing Market Size by Region (2020-2025)
4.2 Global Sepsis Diagnostics Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sepsis Diagnostics Testing Market Size Growth (2020-2025)
4.4 APAC Sepsis Diagnostics Testing Market Size Growth (2020-2025)
4.5 Europe Sepsis Diagnostics Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Sepsis Diagnostics Testing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Sepsis Diagnostics Testing Market Size by Country (2020-2025)
5.2 Americas Sepsis Diagnostics Testing Market Size by Type (2020-2025)
5.3 Americas Sepsis Diagnostics Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sepsis Diagnostics Testing Market Size by Region (2020-2025)
6.2 APAC Sepsis Diagnostics Testing Market Size by Type (2020-2025)
6.3 APAC Sepsis Diagnostics Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Sepsis Diagnostics Testing Market Size by Country (2020-2025)
7.2 Europe Sepsis Diagnostics Testing Market Size by Type (2020-2025)
7.3 Europe Sepsis Diagnostics Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sepsis Diagnostics Testing by Region (2020-2025)
8.2 Middle East & Africa Sepsis Diagnostics Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Sepsis Diagnostics Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Sepsis Diagnostics Testing Market Forecast
10.1 Global Sepsis Diagnostics Testing Forecast by Region (2026-2031)
10.1.1 Global Sepsis Diagnostics Testing Forecast by Region (2026-2031)
10.1.2 Americas Sepsis Diagnostics Testing Forecast
10.1.3 APAC Sepsis Diagnostics Testing Forecast
10.1.4 Europe Sepsis Diagnostics Testing Forecast
10.1.5 Middle East & Africa Sepsis Diagnostics Testing Forecast
10.2 Americas Sepsis Diagnostics Testing Forecast by Country (2026-2031)
10.2.1 United States Market Sepsis Diagnostics Testing Forecast
10.2.2 Canada Market Sepsis Diagnostics Testing Forecast
10.2.3 Mexico Market Sepsis Diagnostics Testing Forecast
10.2.4 Brazil Market Sepsis Diagnostics Testing Forecast
10.3 APAC Sepsis Diagnostics Testing Forecast by Region (2026-2031)
10.3.1 China Sepsis Diagnostics Testing Market Forecast
10.3.2 Japan Market Sepsis Diagnostics Testing Forecast
10.3.3 Korea Market Sepsis Diagnostics Testing Forecast
10.3.4 Southeast Asia Market Sepsis Diagnostics Testing Forecast
10.3.5 India Market Sepsis Diagnostics Testing Forecast
10.3.6 Australia Market Sepsis Diagnostics Testing Forecast
10.4 Europe Sepsis Diagnostics Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Sepsis Diagnostics Testing Forecast
10.4.2 France Market Sepsis Diagnostics Testing Forecast
10.4.3 UK Market Sepsis Diagnostics Testing Forecast
10.4.4 Italy Market Sepsis Diagnostics Testing Forecast
10.4.5 Russia Market Sepsis Diagnostics Testing Forecast
10.5 Middle East & Africa Sepsis Diagnostics Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Sepsis Diagnostics Testing Forecast
10.5.2 South Africa Market Sepsis Diagnostics Testing Forecast
10.5.3 Israel Market Sepsis Diagnostics Testing Forecast
10.5.4 Turkey Market Sepsis Diagnostics Testing Forecast
10.6 Global Sepsis Diagnostics Testing Forecast by Type (2026-2031)
10.7 Global Sepsis Diagnostics Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Sepsis Diagnostics Testing Forecast
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Sepsis Diagnostics Testing Product Offered
11.1.3 Abbott Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Axis Shield
11.2.1 Axis Shield Company Information
11.2.2 Axis Shield Sepsis Diagnostics Testing Product Offered
11.2.3 Axis Shield Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Axis Shield Main Business Overview
11.2.5 Axis Shield Latest Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Information
11.3.2 Becton Dickinson Sepsis Diagnostics Testing Product Offered
11.3.3 Becton Dickinson Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Becton Dickinson Main Business Overview
11.3.5 Becton Dickinson Latest Developments
11.4 产颈辞惭茅谤颈别耻虫
11.4.1 产颈辞惭茅谤颈别耻虫 Company Information
11.4.2 产颈辞惭茅谤颈别耻虫 Sepsis Diagnostics Testing Product Offered
11.4.3 产颈辞惭茅谤颈别耻虫 Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 产颈辞惭茅谤颈别耻虫 Main Business Overview
11.4.5 产颈辞惭茅谤颈别耻虫 Latest Developments
11.5 Bruker
11.5.1 Bruker Company Information
11.5.2 Bruker Sepsis Diagnostics Testing Product Offered
11.5.3 Bruker Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bruker Main Business Overview
11.5.5 Bruker Latest Developments
11.6 Cytosorbents
11.6.1 Cytosorbents Company Information
11.6.2 Cytosorbents Sepsis Diagnostics Testing Product Offered
11.6.3 Cytosorbents Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Cytosorbents Main Business Overview
11.6.5 Cytosorbents Latest Developments
11.7 Danaher
11.7.1 Danaher Company Information
11.7.2 Danaher Sepsis Diagnostics Testing Product Offered
11.7.3 Danaher Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Danaher Main Business Overview
11.7.5 Danaher Latest Developments
11.8 Immunexpress
11.8.1 Immunexpress Company Information
11.8.2 Immunexpress Sepsis Diagnostics Testing Product Offered
11.8.3 Immunexpress Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Immunexpress Main Business Overview
11.8.5 Immunexpress Latest Developments
11.9 Luminex
11.9.1 Luminex Company Information
11.9.2 Luminex Sepsis Diagnostics Testing Product Offered
11.9.3 Luminex Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Luminex Main Business Overview
11.9.5 Luminex Latest Developments
11.10 Mitsubishi Chemical
11.10.1 Mitsubishi Chemical Company Information
11.10.2 Mitsubishi Chemical Sepsis Diagnostics Testing Product Offered
11.10.3 Mitsubishi Chemical Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mitsubishi Chemical Main Business Overview
11.10.5 Mitsubishi Chemical Latest Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Sepsis Diagnostics Testing Product Offered
11.11.3 Response Biomedical Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 Roche
11.12.1 Roche Company Information
11.12.2 Roche Sepsis Diagnostics Testing Product Offered
11.12.3 Roche Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Roche Main Business Overview
11.12.5 Roche Latest Developments
11.13 T2 Biosystems
11.13.1 T2 Biosystems Company Information
11.13.2 T2 Biosystems Sepsis Diagnostics Testing Product Offered
11.13.3 T2 Biosystems Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 T2 Biosystems Main Business Overview
11.13.5 T2 Biosystems Latest Developments
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Information
11.14.2 Thermo Fisher Scientific Sepsis Diagnostics Testing Product Offered
11.14.3 Thermo Fisher Scientific Sepsis Diagnostics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Thermo Fisher Scientific Main Business Overview
11.14.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂